Delivery Order SPE2DR25D2014-SPE2DR26FA0Q4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,819.99 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on December 19, 2025. This is a firm fixed price delivery order with an ultimate completion date of December 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a $62,396.87 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on November 14, 2025, with an ultimate completion date of November 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $33,241.61 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,107.42 for Zepbound 7.5 mg/0.5 ml pen injections, with an ultimate completion date of December 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value...
- The Defense Logistics Agency awarded a $1,348 delivery order to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 mL pen injections on September 22, 2025, with completion targeted for September 23, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply agreement running through December 2026. The product will...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections (0.5 mL units). This competitively awarded, firm fixed-price delivery order carries a ceiling value of $20,677.02 and is scheduled for completion by October 17, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a $29,890.41 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on October 28, 2025, with an ultimate completion date of October 29, 2025. This contract represents a non-set-aside competitive award, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,468.28 to supply Zepbound 7.5 mg/0.5 mL pen injections on June 2, 2025, with completion targeted for June 3, 2025. This competitively awarded, non-set-aside order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections with a ceiling value of $4,783.20. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,649.31 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injectors, with an ultimate completion date of December 19, 2025. This contract represents a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its place of performance in the same location....
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0Q4Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $32,773.68 for Zepbound 12.5 mg/0.5 mL pen injections, with an ultimate completion date of December 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support platform. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a critical federal vendor supplying a broad spectrum of pharmaceutical products and medical supplies to military and veteran healthcare systems. The Zepbound delivery order represents a component of the company's extensive portfolio of federal medical product deliveries, which includes diabetes medications, neurological treatments, pain management pharmaceuticals, vaccines, and specialized medical devices. As a child contract under the larger SPE2DX IDC framework, this delivery order enables the company to efficiently supply pharmaceutical commodities to support Defense Health Agency operations and other federal healthcare customers through flexible contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.8k | 12/21/25 |